publication venue for
- Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.. 18:-. 2024
- Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023.. 18:-. 2024
- Modifiable in-hospital factors for 12-month global cognition, post-traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID-19.. 17:-. 2023
- Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress.. 16:680-689. 2022
- Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.. 7 Suppl 2:82-86. 2013